Lupus Science and Medicine (Nov 2020)
Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
- Laurent Arnaud,
- Zahir Amoura,
- Thierry Martin,
- Anne-Sophie Korganow,
- Aurélien Guffroy,
- Jean Sibilia,
- François Maurier,
- Bernard Bonnotte,
- Andreas Schwarting,
- Gilles Blaison,
- Pierre Kieffer,
- Nadine Magy-Bertrand,
- J Sibilia,
- Yannick Dieudonne,
- C Fiehn,
- M Rizzi,
- R Voll,
- Z Amoura,
- C Sordet,
- M Bartsch,
- A Schwarting,
- L Arnaud,
- Christoph Fiehn,
- JE Gottenberg,
- R Max,
- H-H Peter,
- J-L Pasquali,
- T Martín,
- A Meyer,
- J Thiel,
- P Kieffer,
- N Venhoff,
- H Lorenz,
- F Maurier,
- Aurore Meyer,
- Hannes Martin Lorenz,
- Jean-Louis Pennaforte,
- Hans-Hartmut Peter,
- Reinhard Edmund Voll,
- G Blaison,
- B Bonnotte,
- E Chatelus,
- E Ciobanu,
- F Duchene,
- JP Faller,
- A Gorse,
- O Hinschberger,
- F Jaeger,
- M Kilifa,
- N Magy-Bertrand,
- L Martzolff,
- J-L Pennaforte,
- V Poindron,
- S Revuz,
- M Samson,
- A Theulin,
- D Wahl,
- JC Weber,
- N Bartholomä,
- S Finzel,
- A Funkert,
- M Hausberg
Affiliations
- Laurent Arnaud
- 1 Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d`Immuno Rhumatologie Moléculaire, INSERM UMR_S1109, Strasbourg, France
- Zahir Amoura
- Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France
- Thierry Martin
- 2 Centre National de Références des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, Strasbourg, France
- Anne-Sophie Korganow
- 3Centre National de Référence des maladies auto-immunes et systémiques rares Est/Sud-Ouest (RESO)
- Aurélien Guffroy
- 3Centre National de Référence des maladies auto-immunes et systémiques rares Est/Sud-Ouest (RESO)
- Jean Sibilia
- 1 Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d`Immuno Rhumatologie Moléculaire, INSERM UMR_S1109, Strasbourg, France
- François Maurier
- Private Metz Hospital, Metz, France
- Bernard Bonnotte
- EFS, INSERM, UMR RIGHT, Franche-Comté University, Besançon, France
- Andreas Schwarting
- Rheumatology Center Rhineland Palatinate, Bad Kreuznach, Germany
- Gilles Blaison
- 3Hôpitaux de Colmar, Colmar, France
- Pierre Kieffer
- 4Hôpitaux de Mulhouse, Mulhouse, France
- Nadine Magy-Bertrand
- Department of Internal Medicine, CHU de Besançon, Besançon, France
- J Sibilia
- COMEDRA working group, Paris, France
- Yannick Dieudonne
- Department of Clinical Immunology and Internal Medicine, National Reference Center for autoimmune diseases (RESO), Strasbourg University Hospital, Strasbourg, France
- C Fiehn
- 7Rheumatology, ACURA Centre, Baden Baden
- M Rizzi
- Rheumatology/Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
- R Voll
- 3University Medical Center, Freiburg
- Z Amoura
- 2Hôpital Pitié-Salpêtrière, Paris, France
- C Sordet
- 11Rheumatology, Hautepierre Hospital, Strasbourg
- M Bartsch
- A Schwarting
- 3ACURA Kliniken, Bad Kreuznach, Germany
- L Arnaud
- 1Rheumatology
- Christoph Fiehn
- ACURA Centre for Rheumatic Diseases, Baden-Baden, Germany
- JE Gottenberg
- R Max
- H-H Peter
- Med. Universitätsklinik Freiburg, Freiburg, Germany
- J-L Pasquali
- T Martín
- National Referral Center for Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- A Meyer
- 1Hôpitaux Universitaires de Strasbourg, Strasbourg
- J Thiel
- Rheumatology/Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
- P Kieffer
- N Venhoff
- Rheumatology/Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
- H Lorenz
- F Maurier
- 2Hôpitaux Privés de Metz, Metz
- Aurore Meyer
- Service d`immunologie clinique et médecine interne, Hopitaux universitaires de Strasbourg, Strasbourg, Alsace, France
- Hannes Martin Lorenz
- Department of Medicine V, University Hospital Heidelberg, Center for Rheumatic Diseases Baden-Baden, Heidelberg, Germany
- Jean-Louis Pennaforte
- Department of Internal Medicine, CHU de Reims, Hôpital Robert Debré, Reims, France
- Hans-Hartmut Peter
- Department of Rheumatology and Clinical Immunology, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Reinhard Edmund Voll
- Dept. of Rheumatology and Clinical Immunology, Freiburg University, Medical Centre, Freiburg, Germany
- G Blaison
- B Bonnotte
- E Chatelus
- National Referral Center for Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- E Ciobanu
- F Duchene
- JP Faller
- A Gorse
- O Hinschberger
- F Jaeger
- M Kilifa
- N Magy-Bertrand
- L Martzolff
- J-L Pennaforte
- V Poindron
- National Referral Center for Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- S Revuz
- M Samson
- 10Department of Internal Medicine, Hôpital François-Mitterrand, Dijon
- A Theulin
- D Wahl
- JC Weber
- N Bartholomä
- S Finzel
- Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany
- A Funkert
- M Hausberg
- DOI
- https://doi.org/10.1136/lupus-2020-000399
- Journal volume & issue
-
Vol. 7,
no. 1
Abstract
Objective Systemic lupus is a chronic autoimmune disease characterised by its phenotypic heterogeneity. Neutropaenia is a frequent event in SLE occurring in 20%–40% of patients depending on the threshold value of neutrophil count. On a daily basis, the management of neutropaenia in SLE is difficult with several possible causes. Moreover, the infectious consequences of neutropaenia in SLE remain not well defined.Methods 998 patients from the Lupus BioBank of the upper Rhein (LBBR), a large German and French cohort of patients with SLE, mostly of Caucasian origin (83%), were included in this study. Neutropaenia was considered when neutrophil count was below 1800×106/L. An additional analysis of detailed medical records was done for 65 LBBR patients with neutropaenia.Results 208 patients with neutropaenia (21%) were compared with 779 SLE patients without neutropaenia. Neutropaenia in SLE was significantly associated with thrombocytopaenia (OR 4.11 (2.57–10.3)), lymphopaenia (OR 4.41 (2.51–11.5)) and low C3 (OR 1.91 (1.03–4.37)) in multivariate analysis. 65 representative patients with neutropaenia were analysed. Neutropaenia was moderate to severe in 38%, chronic in 31%, and both severe and chronic in 23% of cases. Moderate to severe and chronic neutropaenia were both associated with lymphopaenia and thrombopaenia. Chronic neutropaenia was also associated anti-Ro/SSA antibodies and moderate to severe neutropaenia with oral ulcers.Conclusion This study is to date the largest cohort to describe neutropaenia in SLE. Neutropaenia displays a strong association with other cytopaenias, suggesting a common mechanism. Chronic neutropaenia is associated with anti-Ro/SSA antibodies with or without identified Sjögren’s disease.